ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 641172 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 641172; 2) Community: the network communities that were significantly associated with the response to NSC 641172; 3) Molecule: the relationships between components within communities and NSC 641172; 4) MDR: the compounds that were significantly associated with the NSC 641172.

NSC Compound Enrichment Correlation
NSC 749169 8H-thieno[2'3':4,5]pyrimido[2,1-a]phthalazin-8-one,5-[[3-(dimethylamino)propyl]amino]-9,10-dimethyl 0.0130238833303634 -0.043590256
NSC 749600 Null 0.0130238833303634 0.071484058
NSC 753456 2-4-[5-(3,5-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,6,7-trimethoxy-1,3-benzothiazole 0.0130238833303634 0.1848236
NSC 758670 TANNIC ACID 0.0130238833303634 0.19957941
NSC 762901 trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide 0.0130238833303634 0.15591866
NSC 645317 Sanguilutine pseudobase 0.0152777849043084 0.46706513
NSC 645330 11H-Benzo[a]carbazole-1,4-dione, 7,11-dimethyl- 0.0152777849043084 0.17334466
NSC 661415 2-Chloro-3-(2-butoxyethoxy)naphthazarin 0.0152777849043084 0.19289011
NSC 663285 6-N-(Aminoethyl-2-(4-morpholino))-6-chloro-5,8-quinolinedione 0.0152777849043084 0.38808864
NSC 676769 Null 0.0152777849043084 0.23626214
Total:112  Current:31    [First] [Prev] [Next] [Last]